Authors : Kirinendji F A; Diarra R D; Goni Y A; Tekpa G; Diemer HSC; Mbodji M; Konta M; Dolo H

Volume/Issue : Volume 10 - 2025, Issue 5 - May

Google Scholar : https://tinyurl.com/4w9fmxvd

Scribd : https://tinyurl.com/3y4xtzm5

DOI : https://doi.org/10.38124/ijisrt/25may2010

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 30 to 40 days to display the article.

Abstract : Introduction In Central African Republic, the community approach plays a key role in the fight against tuberculosis. Our objective was to assess anti-tuberculosis treatment adherence, obstacles and facilitators to community monitoring of tuberculosis in Bangui.  Methodology We conducted an analytical cross-sectional study among patients treated for at least one month for tuberculosis at three sites in Bangui. A kobocollecte questionnaire was used to collect data that were analyzed using SPSS V25 software (risk α = 5%). The qualitative part based on individual and group interviews explored the obstacles and facilitators to communication between CHWs and tuberculosis patients. Data analysis was performed using NVIVO V14 software.  Results 262 patients with a mean age of 35.11±12.88 years were included; the sex ratio was 1.54. The frequency of poor compliance was 13.8%. In univariate analysis, the factors associated with poor compliance were lack of instruction and non- acceptance of home visits by community health workers (p=0.034 and p=0.040 respectively). Barriers to communication between CHWs and patients were fear of stigma, hunger, lack of information about CHWs, non-compliance with the specifications and poor working conditions. Facilitators included community distribution of anti-tuberculosis drugs, nutritional support, peer support and visual aids.  Conclusion The implementation of community engagement faces challenges requiring a combined approach, tailored to the needs of beneficiaries.

Keywords : Evaluation, Compliance, Anti-Tuberculosis Treatment, Community Monitoring.

References :

[1].    Tékpa G, Fikouma V, Téngothi RMM, Longo J de D, Woyengba APA, Koffi B. Epidemiological and clinical aspects of tuberculosis in a hospital setting in Bangui. Pan Afr Med J. 2019 May 15;33:31.
[2].    WHO. Global tuberculosis report [Internet]. Geneva; 2020 [cited 5 Apr 2024]. Available from: https://iris.who.int/bitstream/handle/10665/336069/9789240013131-eng.pdf?sequence
[3].    WHO. Global tuberculosis report [Internet]. Geneva: WHO; 2023 [cited 22 Jan 2024]. Available from: https://iris.who.int/bitstream/handle/10665/373828/9789240083851-eng.pdf?sequence
[4].    USAID. U said's global tuberculosis (tb) strategy 2023–2030 [Internet]. 2023 [cited 8 Apr 2024]. Available at: https://www.usaid.gov/sites/default/files/2022-12/SinglePage-USAIDTB-StratDoc-For508.v3.pdf
[5].    PNLT. National strategic plan to combat tuberculosis 2024-2028. Ministry of Health and Population. Central African Rep. 2024.
[6].    Garbrah BG, Abebrese J, Owusu-Marfo J. Factors associated with tuberculosis treatment adherence among tuberculosis patients in the Kumasi metropolis in the Ashanti Region of Ghana; A cross-sectional study. J Public Health (Berl) [Internet]. July 3, 2023 [cited September 27, 2024]; Available at: https://doi.org/10.1007/s10389-023-02002-3
[7].    WHO. WHO practical guide to tuberculosis. Module 1 : Prevention - preventive treatment of tuberculosis [Internet]. Geneva; 2021 [cited 6 Apr 2024]. 160 pp. Available from: https://iris.who.int/bitstream/handle/10665/345326/9789240034655-zeng.pdf?sequence
[8].    PNLT. Ministry of Health and Population. Guide to the management of tuberculosis in adults. 5th edition. Central African Republic; 2021. 57 p.
[9].    Nezenega ZS, Perimal-Lewis L, Maeder AJ. Factors Influencing Patient Adherence to Tuberculosis Treatment in Ethiopia: A Literature Review. Int J Environ Res Public Health. August 2020;17(15):5626.
[10].    Diarra K. Evaluation of Tuberculosis Management in Koro from 2019 to 2021 according to the National Guidelines of Mali. 2022 [cited 31 Jan 2025]; Available at: https://www.bibliosante.ml/handle/123456789/5737
[11].    Kallon I. The status of community health workers in Africa: a review of the literature on primary health care initiatives. Public Services International. The International Federation of Workers in Public Services. 2020.
[12].    Getachew A, Silumbwe A, Maritim P, Hangoma P, Belete A, Zulu JM. An evaluation of community acceptability and adoption of the community-based TB care program using the diffusion of innovation model. Journal of Community Systems for Health [Internet]. 1 Oct 2024 [cited 9 Oct 2024];1(1). Available at: https://journals.ub.umu.se/index.php/jcsh/article/view/1072
[13].    CSLS-TBH. Ministry of Health and Social Development. Revised Integrated National Strategic Plan 2023-2026 to combat HIV/AIDS, Tuberculosis and Viral Hepatitis in Mali [Internet]. 2023 [cited 8 Apr 2024]. Available at: https://files.aho.afro.who.int/afahobckpcontainer/production/files/PSNI_Mali_2023-2026_Version_du_09082023.pdf
[14].    Ayala A, Ncogo P, Eyene J, García B, Benito A, Romay-Barja M. Rural-Urban Inequities in Tuberculosis-Related Practices in Equatorial Guinea. J Epidemiol Glob Health. Dec 2023;13(4):886‑94.
[15].    Doyama-woza RH, Fandema E, Piamalé G, Dhuih Djidere AF, Ignaleamoko A, Diemer SCH, et al. Risk factors for multidrug-resistant pulmonary tuberculosis in Bangui. Health Research in Africa. 2024;30‑4.
[16].    Laghari M, Talpur BA, Sulaiman SAS, Khan AH, Bhatti Z. Assessment of adherence to anti-tuberculosis treatment and predictors for non-adherence among the caregivers of children with tuberculosis. Trans R Soc Trop Med Hyg. 2 Aug 2021;115(8):904‑13.
[17].    Tekpa G, Inikoutiyo J, Yonli C, Noguera C, Lujwiro PP, Gigout L, et al. Retention on antiretroviral therapy and drivers of lost-to-follow up in the Central African Republic: a longitudinal analysis. J Int AIDS Soc. Dec 2024;27(12):e26387.
[18].    Dje Bi IH, Anon JC, Yeo L, Toh Bi Y, Achi V, Meliane NS. Factors of poor adherence to antitubercular treatment in Bouaké. Review of Respiratory Diseases. 1 Jan 2019;36:A258‑9.
[19].    Aderemi-Williams RI, Nduaguba SO, Akoji EM, Ogbo PU, Abah IO. Drug therapy problems identified among patients receiving antiretroviral treatment in a HIV clinic: a prospective study in North Central, Nigeria. The Pan African Medical Journal [Internet]. 16 déc 2021 [cité 2 févr 2025];40(233). Disponible sur: https://www.panafrican-med-journal.com//content/article/40/233/full
[20].    Aderemi-Williams RI, Razaq AR, Abah IO, Opanuga OO, Akanmu AS. Adolescents and Young Adults Knowledge, Adherence and Experiences While on Antiretroviral Therapy in a Tertiary Hospital in Lagos, Nigeria: A Mixed-Method Study. J Int Assoc Provid AIDS Care. 1 janv 2021;20:23259582211062754.
[21].    Coulibaly MB, Niangaly AA, Keita Z, Sylla O. Epidemiological profile, diagnosis and evolution of tuberculosis in the community setting in the diagnostic and treatment center of Konobougou, Mali. Malian Journal of Infectiology and Microbiology. 2020 Nov 27;15(2):43‑7.
[22].    Leddy A, Ggita J, Berger CA, Kityamuwesi A, Sanyu AN, Tinka LK, et al. Barriers and Facilitators to Implementing a Digital Adherence Technology for Tuberculosis Treatment Supervision in Uganda: Qualitative Study. J Med Internet Res. May 30, 2023;25:e38828.
[23].    Ajema D, Shibru T, Endalew T, Gebeyehu S. Level of and associated factors for non-adherence to anti-tuberculosis treatment among tuberculosis patients in Gamo Gofa zone, southern Ethiopia: cross-sectional study. BMC Public Health. 13 Nov 2020;20:1705.
[24].    Wafa B, Oumayma A, Asthma K, Rania M, Asthma A, Asthma C, et al. Factors associated with poor adherence to antituberculosis therapy. Review of Respiratory Diseases Updates. 1 Jan 2023;15(1):166.
[25].    Getahun T, Debebe H, Getahun H, Abebe Y, Assefa K, Habtemichael M. Antituberculosis Drug Nonadherence and Its Associated Factors: Evidence from Debre Berhan Town, North Shewa Zone, Ethiopia. Tuberc Res Treat. 29 Apr 2023 ; 2023:7645058.
[26].    Gebreweld FH, Kifle MM, Gebremicheal FE, Simel LL, Gezae MM, Ghebreyesus SS, et al. Factors influencing adherence to tuberculosis treatment in Asmara, Eritrea: a qualitative study. J Health Popular Nutr. 5 Jan 2018;37(1):1.
[27].    Thomas BE, Kumar JV, Onongaya C, Bhatt SN, Galivanche A, Periyasamy M, et al. Explaining Differences in the Acceptability of 99DOTS, a Cell Phone-Based Strategy for Monitoring Adherence to Tuberculosis Medications: Qualitative Study of Patients and Health Care Providers. JMIR Mhealth Uhealth. 31 juill 2020;8(7):e16634.
[28].    Farra A, Koula K, Jolly BL, Gando HG, Ouarandji LM, Mossoro-Kpinde CD, et al. Effectiveness of Xpert MTB/RIF and the Line Probe Assay tests for the rapid detection of drug-resistant tuberculosis in the Central African Republic. PLOS Glob Public Health. 2023; 3 (5):e0001847.
[29].    Sangho O, Ouattara S, Telly N, Ballayira Y, Coulibaly CA, Traoré B, et al. Evaluation of the management of patients with drug-sensitive pulmonary tuberculosis at the Reference Health Center, Commune V of Bamako, 2015-2018. Malian Journal of Infectiology and Microbiology. 2021 Jun 2;16(2):26-31.
[30].    PNLT. Guide to the management of adult tuberculosis. Ministry of Health and Population. Central African Republic. 2024.
[31].    Potty RS, Kumarasamy K, Adepu R, Reddy RC, Singarajipura A, Siddappa PB, et al. Community health workers increase the cCHWade of TB detection to care in urban slums of two metro cities in India. J Glob Health. 11:04042.
[32].    Pinnock H, Barwick M, Carpenter CR, Eldridge S, Grandes G, Griffiths CJ, et al. Standards for Reporting Implementation Studies (StaRI): explanation and elaboration document. BMJ Open. avr 2017;7(4):e013318.
[33].    Wroe EB, Nhlema B, Dunbar EL, Kulinkina AV, Kachimanga C, Aron M, et al. A household-based community health worker programme for non-communicable disease, malnutrition, tuberculosis, HIV and maternal health: a stepped-wedge cluster randomised controlled trial in Neno District, Malawi. BMJ Glob Health. sept 2021;6(9):e006535.
[34].    Gube AA, Debalkie M, Seid K, Bisete K, Mengesha A, Zeynu A, et al. Assessment of Anti-TB Drug Nonadherence and Associated Factors among TB Patients Attending TB Clinics in Arba Minch Governmental Health Institutions, Southern Ethiopia. Tuberc Res Treat. 2018; 2018:3705812.
[35].    Batte C, Namusobya MS, Kirabo R, Mukisa J, Adakun S, Katamba A. Prevalence and factors associated with non-adherence to multi-drug resistant tuberculosis (MDR-TB) treatment at Mulago National Referral Hospital, Kampala, Uganda. Afr Health Sci. mars 2021;21 (1):238‑47.
[36].    Lukyamuzi Z, Ssuna B, Mirembe RN, Mawanda D, Kinkumu P, Nalugo C, et al. Experiences and challenges of using community health worker-led mechanism in supporting HIV disclosure among adults living with HIV in heterosexual relationships in the rural Uganda. AIDS Res Ther. 11 mars 2023;20 (1):14.
[37].    Taylor M, Medley N, van Wyk SS, Oliver S. Community views on active case finding for tuberculosis in low- and middle-income countries: a qualitative evidence synthesis. Cochrane Database Syst Rev. 21 mars 2024;3(3):CD014756.
[38].    Seytre B. (PDF) The challenges of communicating about tuberculosis in Côte d'Ivoire. ResearchGate. 22 Oct 2024;3(33):415‑23.
[39].    Stern AD, Brönneke J, Debatin JF, Hagen J, Matthies H, Patel S, et al. Advancing digital health applications: priorities for innovation in real-world evidence generation. Lancet Digit Health. March 2022;4 (3):e200‑6.
[40].    Van Bavel JJ, Cichocka A, Capraro V, Sjåstad H, Nezlek JB, Pavlović T, et al. Author Correction: National identity predicts public health support during a global pandemic. Nat Commun. Apr 6, 2022 ; 13(1):1949.
[41].    Saluzzo F, Espinosa-Pereiro J, Dressler S, Tavora Dos Santos Filho E, Seidel S, Gonzalez Moreno J, et al. Community engagement in tuberculosis research: the EU-Patient-centric clinical trial platforms (EU-PEARL) experience. Int J Infect Dis. May 2023;130 Suppl 1:S20‑4.